Clinical trial
Prospective Stratification of Infectious Risks in Multiple Sclerosis (InRIMS-Study)
NCT04036097 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Stratification of Infectious Risks in Multiple Sclerosis (InRIMS-Study)
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 10, 2019
- Completion date
- December 31, 2023
- Enrollment
- 298 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.